Elekta, the Stokholm, Sweden-based supplier of radiation oncology and neurosurgery systems, announced today that its Leksell Gamma Knife Icon stereotactic radiosurgery system (SRS) was used to treat a patient in the United States for the first time.
The treatment was used to treat a metastatic brain tumor using a frameless approach integrated with a novel high definition motion management, an important feature of the company’s new SRS, according to Eleckta North American Executive Vice President Bill Yaeger.
"Elekta is ecstatic that Gamma Knife Icon is now being used in the U.S., and we commend Sutter Medical Center Gamma Knife Center for being an early adopter of the newest SRS technology," Yaeger said in a press release. "We strive to give neurosurgeons and radiation oncologists the tools they need to effectively treat the target and protect healthy brain tissue. Gamma Knife Icon exemplifies that commitment and brings a new treatment option to the hundreds of thousands of people living with brain diseases. We are excited to be working with other leading centers across the U.S. to install additional Gamma Knife Icon systems over the coming months."